Risperdal Depot Formulation May Aid Compliance Among Schizophrenics

Janssen and Alkermes are collaborating to develop a depot formulation of the antipsychotic Risperdal that would be delivered via injection once every two weeks. Risperdal is currently available in daily tablet or oral solution formulations.